Cardiac Injury Markers in Non-elite Marathon Runners

 

 Buy Article Permissions and Reprints

Abstract

An elevation of cardiac injury markers including creatinine kinase (CK), myoglobin (Myo) and cardiac troponin T (cTnT) has been observed in elite athletes following strenuous exercise. The mechanism and significance of this observation however have not been fully elucidated. The goals of this study were: 1) to determine whether these changes in biomarkers also occur in a large, heterogeneous group of non-elite athletes; and 2) to identify possible clinical or biochemical associations. We recruited 129 non-elite runners in 2006, 61 individuals who were taking part in the half (13.1 miles) marathon and 68 individuals participating in the full (26.2 miles) marathon. Demographic data and blood samples were collected for analysis of CK, Myo, cTnT, and Creatinine (Cr) levels within two hours of race start, at race completion, and 1-h post-race for both patient cohorts. In the 61 individuals (40 males, 40±12 yrs) completing the half marathon in a mean time of 150±20 min, 90.3%, 65.2%, and 30.6% of the subjects exhibited significant elevations in Myo, CK, and cTnT, respectively immediately post race and 100%, 74.9% and 45.9% in the same biomarkers one hour-post race. In the 68 individuals (44 males, 42±14 yrs) completing the full marathon in a mean time of 310±30 min, 95.3%, 70.2% and 35.7% exhibited significant elevations in Myo, CK and cTnT respectively immediately post race and 100%, 78.5% and 52.8% in the same biomarkers one hour-post race. The elevation in cTnT levels post-race were modestly associated with the time required to complete the race for the entire cohort of marathon runners. The serum levels of Cr, CK, and Myo post-race did not correlate however with age, sex, BMI, level of training, or prior marathon experience. Elevations of cardiac injury markers in non-elite athletes are extremely common following the completion of endurance events and correlate to the increased endurance time. Whether the increase in the levels of these enzymes represents true myocardial injury or a result of the release of cTnT from the myocytes requires further investigation.

References

• 1 Abaci A, Ekici E, Oguzhan A, Tokgoz B, Utas C. Cardiac troponins T and I in patients with end-stage renal disease: the relation with left ventricular mass and their prognostic value.  Clin Cardio. 2004;  27 704-709
  PubMedGoogle Scholar
• 2 Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations.  Clin Chem. 2003;  49 1331-1336
  CrossrefPubMedGoogle Scholar
• 3 Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury.  CMAJ. 2005;  173 1191-1202
  CrossrefPubMedGoogle Scholar
• 4 Chen Y, Serfass RC, Mackey-Bojack SM, Kelly KL, Titus JL, Apple FS. Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged intense exercise.  J Appl Physiol. 2000;  88 1749-1755
  PubMedGoogle Scholar
• 5 Fortescue EB, Shin AY, Greenes DS, Mannix RC, Agarwal S, Feldman BJ, Shah MI, Rifai N, Landzberg MJ, Newburger JW, Almond CS. Cardiac troponin increases among runners in the Boston Marathon.  Ann Emerg Med. 2007;  49 137-143
  CrossrefPubMedGoogle Scholar
• 6 George K, Whyte G, Stephenson C, Shave R, Dawson E, Edwards B, Gaze D, Collinson P. Postexercise left ventricular function and cTnT in recreational marathon runners.  Med Sci Sports Exerc. 2004;  36 1709-1715
  CrossrefPubMedGoogle Scholar
• 7 Herrmann M, Scharhag J, Miclea M, Urhausen A, Herrmann W, Kindermann W. Post-race kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners.  Clin Chem. 2003;  49 831-834
  CrossrefPubMedGoogle Scholar
• 8 Laslett L, Eisenbud E. Lack of detection of myocardial injury during competitive races of 100 miles lasting 18 to 30 h.  Am J Cardiol. 1997;  80 379-380
  CrossrefPubMedGoogle Scholar
• 9 Neilan TG, Januzzi JL, Lee-Lewandrowski E, Ton-Nu TT, Yoerger DM, Jassal DS, Lewandrowski KB, Siegel AJ, Marshall JE, Douglas PS, Lawlor D, Picard MH, Wood MJ. Myocardial injury and ventricular dysfunction related to training levels among non-elite participants in the Boston marathon.  Circulation. 2006;  114 2325-2333
  CrossrefPubMedGoogle Scholar
• 10 Neumayr G, Pfister R, Mitterbauer G, Eibl G, Hoertnagl H. Effect of competitive marathon cycling on plasma N-terminal pro-brain natriuretic peptide and cardiac troponin T in healthy recreational cyclists.  Am J Cardiol. 2005;  96 732-735
  CrossrefPubMedGoogle Scholar
• 11 Rifai N, Douglas PS, O’Toole E, Rimm E, Ginsburg GS. Cardiac troponin T and I, echocardiographic wall motion analyses and ejection fractions in athletes participating in the Hawaii Ironman Triathlon.  Am J Cardiol. 1999;  83 1085-1089
  CrossrefPubMedGoogle Scholar
• 12 Scharhag J, Herrmann M, Urhausen A, Haschke M, Herrmann W, Kindermann W. Independent elevations of N-Terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise.  Am Heart J. 2005;  150 1128-1134
  CrossrefPubMedGoogle Scholar
• 13 Scharhag J, Urhausen A, Schneider G, Herrmann M, Schumacher K, Haschke M, Krieg A, Meyer T, Hermann W, Kindermann W. Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide in endurance athletes.  Eur J Cardiovasc Prev Rehabil. 2006;  13 388-397
  CrossrefPubMedGoogle Scholar
• 14 Shave RE, Dawson E, Whyte G, George K, Ball D, Gaze DC, Collinson PO. Evidence of exercise-induced cardiac dysfunction and elevated cTnT in separate cohorts competing in an ultra-endurance mountain marathon race.  Int J Sports Med. 2002;  23 489-494
  Article in Thieme ConnectPubMedGoogle Scholar
• 15 Shave RE, Dawson E, Whyte PG, George K, Ball D, Gaze CD, Collinson P. Cardiac troponin T in female athletes during a two-day mountain marathon.  Scott Med J. 2003;  48 41-42
  PubMedGoogle Scholar
• 16 Shave R, Dawson E, Whyte G, George K, Gaze D, Collinson P. Altered cardiac function and minimal cardiac damage during prolonged exercise.  Med Sci Sports Exerc. 2004;  36 1098-1103
  CrossrefPubMedGoogle Scholar
• 17 Shave R, Dawson E, Whyte G, George K, Nimmo M, Layden J, Collinson P, Gaze D. The impact of prolonged exercise in a cold environment upon cardiac function.  Med Sci Sports Exerc. 2004;  36 1522-1527
  CrossrefPubMedGoogle Scholar
• 18 Shave R, George KP, Atkinson G, Hart E, Middleton N, Whyte G, Gaze D, Collinson PO. Exercise-induced cardiac troponin T release: a meta-analysis.  Med Sci Sports Exerc. 2007;  39 2099-2106
  CrossrefPubMedGoogle Scholar
• 19 Shave RE, Whyte GP, George K, Gaze DC, Collinson PO. Prolonged exercise should be considered alongside typical symptoms of acute myocardial infarction when evaluating increases in cardiac troponin T.  Heart. 2005;  91 1219-1220
  CrossrefPubMedGoogle Scholar
• 20 Smith JE, Garbutt G, Lopes P, Pedoe DT. Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department.  Br J Sports Med. 2004;  38 292-294
  CrossrefPubMedGoogle Scholar
• 21 Thygesen K, Alert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction . Universal definition of myocardial infarction.  J Am Coll Cardiol. 2007;  50 2173-2195
  CrossrefPubMedGoogle Scholar
• 22 Urhausen A, Scharhag J, Herrmann M, Kindermann W. Clinical significance of increased cardiac troponins T and I in participants of ultra-endurance events.  Am J Cardiol. 2004;  94 696-698
  CrossrefPubMedGoogle Scholar

Correspondence

Sat Sharma MD, FRCPC, FCCP 

Department of Internal Medicine Head

Section of Respirology University of Manitoba BG 034

St. Boniface General Hospital

409 Tache Avenue

Winnipeg Manitoba Canada

R2H 2A6

Phone: +204/237/22 17

Fax: +204/231/19 27

Email: ssharma@sbgh.mb.ca